More News Articles
- Chugai’s Alecensa Delivers Positive Phase III Results for People with ALK-Positive Early-Stage Lung Cancer
- Personnel Change
- Chugai Files Patent Infringement Lawsuit against Biogen MA Inc. and Bio-Thera Solutions, Ltd. in the U.S.
- Chugai’s Hemlibra Launched for Congenital Hemophilia A without Inhibitors in Taiwan
- Chugai Establishes Corporate Venture Capital to Accelerate Innovation Opportunities with Drug Discovery Start-ups
- New Data from the Japanese Phase III Clinical Trial of Hemlibra for Acquired Hemophilia A (AGEHA Study) Presented at ISTH
- Chugai Files New Drug Application in Japan for Crovalimab for Paroxysmal Nocturnal Hemoglobinuria
- Personnel Change
- New Data Presented at EHA Show Chugai’s Subcutaneously Administered Crovalimab Achieved Disease Control and was Well-Tolerated in People with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Chugai Selected as “DX Platinum Companies 2023-2025” in Digital Transformation Stocks (DX Stocks) 2023
- New Investment of Over 50 Billion Yen in Bio Manufacturing Facilities to Strengthen the Production Base to Support the Rapid Launch of In-House Projects
- Personnel Changes
- Personnel Changes
- Chugai Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for Novartis’ MET Inhibitor, Capmatinib, Which Is Approved for MET Exon 14 Skipping Mutation-Positive Advanced and/or Recurrent Unresectable Non-Small Cell Lung Cancer
- Chugai Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for Novartis’ MET Inhibitor, Capmatinib, Which Is Approved for MET Exon 14 Skipping Mutation-Positive Advanced and/or Recurrent Unresectable Non-Small Cell Lung Cancer
Company Events
Inspiring Students to Pursue Careers in Science
13 March 2023
Staying Connected with Former Colleagues Through the CPR Alumni Network
24 February 2023
Ushering in the Year of the Rabbit
February 3, 2023
Festive Fun: Christmas Cheer at CPR
December 5, 2022
NUS Virtual Talk
October 19, 2022
A Decade of Success: Celebrating Our 10th Anniversary
November 17, 2022
NUS Students Gain Insights into Drug Discovery Research During Lab Visit to CPR
October 12, 2022
Conferment of Honorary Citizen Award to Sir David Lane
25 August 2022
Molecular Biotechnology Talk for NUS
March 22, 2022
NUS Life Sciences Industry Seminar 2022
February 15, 2022
CPR X’mas Party 2021
December 10, 2021
8th Antibody Symposium
November 22, 2021
NUS virtual talk
October 20, 2021
EDB Webinar on Singapore’s Biopharmaceutical Landscape
October 15, 2021
Celebrating CPR’s 9th Anniversary in a Fun-Filled Way Online
July 30, 2021
Fruits Day
2021 Kaizen and 2020 Christmas Party
December 11, 2020
7th Antibody Symposium
November 23, 2020
8th anniversary online party
August 28, 2020
Celebrating Project Achievement
January 09, 2020
2019 Xmas Party
December 20, 2019
2019 Kaizen Presentation
December 19, 2019
7th Anniversary Party
July 26, 2019
1sᴛ Student Visit
February 20, 2019
6th Antibody Symposium in Biopolis, Singapore
September 23, 2019
5th Antibody Symposium in Biopolis, Singapore
March 5-6, 2018
One north Festival
August, 2017
CPR’s 5th Anniversary Party
November 14, 2016
BioPharma Asia Convention 2014
March 10-13, 2014
Biopolis 10th Anniversary Carnival
October 18, 2013
CPR’s 1st Anniversary Party
June 27, 2013
BioPharma Asia Convention 2013
March 19, 2013
4th Antibody Symposium in Biopolis, Singapore
November 14, 2016
3rd Antibody Symposium in Biopolis, Singapore
January 14, 2015
2nd Antibody Symposium in Biopolis, Singapore
September 10, 2013
1st Antibody Symposium in Biopolis, Singapore
September 17, 2012
Official Opening Ceremony
July 13, 2012
